These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
905 related articles for article (PubMed ID: 12063968)
21. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. Irani AM; Craig SS; DeBlois G; Elson CO; Schechter NM; Schwartz LB J Immunol; 1987 Jun; 138(12):4381-6. PubMed ID: 3295046 [TBL] [Abstract][Full Text] [Related]
22. [Distribution of cells containing different IgG and IgA subclasses in the colonic mucosa in childhood ulcerative colitis and Crohn disease]. Arató A; Savilahti E Orv Hetil; 1991 Sep; 132(37):2027-31. PubMed ID: 1923475 [TBL] [Abstract][Full Text] [Related]
23. An easy method to quantify plasma cells/plasma cell precursors in normal colonic mucosa, collagenous colitis and Crohn's colitis. Rubio CA Anticancer Res; 2012 Sep; 32(9):3723-6. PubMed ID: 22993311 [TBL] [Abstract][Full Text] [Related]
24. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Sato T; Nakai T; Tamura N; Okamoto S; Matsuoka K; Sakuraba A; Fukushima T; Uede T; Hibi T Gut; 2005 Sep; 54(9):1254-62. PubMed ID: 16099792 [TBL] [Abstract][Full Text] [Related]
25. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease. Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527 [TBL] [Abstract][Full Text] [Related]
26. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation. Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017 [TBL] [Abstract][Full Text] [Related]
27. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. Banks C; Bateman A; Payne R; Johnson P; Sheron N J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223 [TBL] [Abstract][Full Text] [Related]
29. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease. Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192 [TBL] [Abstract][Full Text] [Related]
30. Macrophage-associated chronic diarrhea of unknown origin. Preliminary observations. Rubio CA In Vivo; 2005; 19(5):927-9. PubMed ID: 16097448 [TBL] [Abstract][Full Text] [Related]
31. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease. Nielsen OH; Brynskov J; Bendtzen K Dan Med Bull; 1993 Apr; 40(2):247-9. PubMed ID: 8495600 [TBL] [Abstract][Full Text] [Related]
32. Differences in yeast intolerance between patients with Crohn's disease and ulcerative colitis. Brunner B; Scheurer U; Seibold F Dis Colon Rectum; 2007 Jan; 50(1):83-8. PubMed ID: 17096175 [TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody 1F10 immunoreactivity in inflammatory bowel disease: a new marker specific only for continuous endothelial cells. Lügering N; Stoll R; Holzgreve A; Winde G; Sorg C; Domschke W Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):777-81. PubMed ID: 7496869 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU). Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654 [TBL] [Abstract][Full Text] [Related]
35. Expression of the Kp43 (CD 94) receptor by natural killer (NK) cells in ulcerative colitis. del Mar Cabrera M; Valle J; Pajares JM; Romero I; Zomeño M; Maté J Hepatogastroenterology; 2001; 48(41):1316-20. PubMed ID: 11677954 [TBL] [Abstract][Full Text] [Related]
37. Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease. Nishiwaki T; Ina K; Goto H; Watanabe O; Tsuzuki T; Furuta R; Ando T; Hibi K; Kusugami K J Gastroenterol; 2005 Feb; 40(2):128-36. PubMed ID: 15770395 [TBL] [Abstract][Full Text] [Related]
38. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis. Jarnum S; Jensen KB Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626 [TBL] [Abstract][Full Text] [Related]
39. Nodular duodenitis involving CD8+ cell infiltration in patients with ulcerative colitis. Honma J; Mitomi H; Murakami K; Igarashi M; Saigenji K; Toyama K Hepatogastroenterology; 2001; 48(42):1604-10. PubMed ID: 11813583 [TBL] [Abstract][Full Text] [Related]
40. Mucosal secretion and expression of basic fibroblast growth factor in patients with collagenous colitis. Taha Y; Raab Y; Larsson A; Carlson M; Lööf L; Gerdin B; Thörn M Am J Gastroenterol; 2003 Sep; 98(9):2011-7. PubMed ID: 14499780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]